PTI
Proteostasis Therapeutics, Inc.
Cormorant Asset Management, LLC bought $2.9M of Proteostasis Therapeutics, Inc.
10% owner
Bought$2,867,700
$11.05Price
259,500Shares
+9%Stake
What PTI did for a copier
Prices for PTI after this filing aren't in yet.
Cormorant Asset Management, LLC's record
17 other buys with 3 months of prices since 2016: on average −6.0% against the S&P 500, and 8 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Nov 9. Filed Mon, Nov 14, 12:33 PM ET, during the session. Not investment advice.